Evaluation of the effect of mucodentol on people with coronavirus
Early Phase 1
- Conditions
- COVID-19.COVID-19U07.1
- Registration Number
- IRCT20130428013151N2
- Lead Sponsor
- Khoram-Abad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Age over 18 years old
Mental and physical ability to use this drug for three weeks
Lack of sensitivity to drugs and similar drugs
People are aware of time, place
person, are mentally and emotionally normal
be able to communicate verbally for telephone interviews
Infected to covid-19
Exclusion Criteria
Lack of cooperation
Do not use the drug regularly
Having corona and need to be hospitalized
Drug sensitivity
Pregnancy and lactation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The symptoms caused by the Covid-19. Timepoint: Three times a day before bed. Method of measurement: In case of home quarantine, since it is advisable for personal protection, people should not leave the house. At the end of the first week, Second and third week, the desired symptoms will be asked and recorded as a telephone interview. In case of hospitalization, patients will be interviewed and examined.
- Secondary Outcome Measures
Name Time Method Fever. Timepoint: daily. Method of measurement: Thermometer.;Respiratory-general symptoms. Timepoint: daily. Method of measurement: yes/no.